Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
07 Febbraio 2025 - 5:58PM
Edgar (US Regulatory)
Exhibit A
Joint Filing Agreement
The undersigned hereby agree that this Statement on Schedule 13G with respect to the beneficial ornership of shares of Common Stock of OPTINOSE, INC. is filed jointly, on behalf of each of them.
Rosalind Advisors, Inc.
By: _____________________________
Name: Steven Salamon
Title: President
Rosalind Malter Fund L.P.
By: _____________________________
Name: Mike McDonald
Title: Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
By: _____________________________
Name: Steven Salamon
NYC#: 139632.2
Grafico Azioni OptiNose (NASDAQ:OPTN)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni OptiNose (NASDAQ:OPTN)
Storico
Da Feb 2024 a Feb 2025
